Loading clinical trials...
Loading clinical trials...
The Effect of Diabetic Peripheral Neuropathy Symptoms on Temporomandibular Joint Functionality in Patients With Type 2 Diabetes
The aim of this observational case-control study was to investigate the effect of diabetic peripheral neuropathy symptoms on temporomandibular joint functionality in patients with type 2 diabetes.
The number of participants planned to be included in the study was decided with the G-Power programme. While calculating the number of individuals to be included in the study, it was calculated that the sample size to obtain an effect size of 0.6 for the purpose of evaluation within the 95% confidence interval in a way to provide 80% study power at 5% Type 1 and 20% Type 2 error limits should be 74 (n=37) individuals. This study included 70 individuals (DM study group=40 individuals, control group=30 individuals). Peripheral neuropathy symptoms of all participants were evaluated with the Michigan Neuropathy Screening Test. In the evaluation of TMJ functionality, the presence of pain, maximum pain-free mouth opening, mandibular dysfunction and dysfunction were assessed with the help of scales. Duration of diabetes mellitus was recorded and quality of life was evaluated with Ferran Powers Quality of Life Index.
Age
48 - 78 years
Sex
ALL
Healthy Volunteers
Yes
Bandirma Onyedi Eylul University
Balıkesir, Bandirma, Turkey (Türkiye)
Start Date
May 1, 2023
Primary Completion Date
November 1, 2023
Completion Date
November 15, 2023
Last Updated
January 5, 2024
70
ACTUAL participants
Michigan Neuropathy Screening Instrument
OTHER
Numeric Pain Scale
OTHER
Mandibular Function Disorder Questionnaire
OTHER
Fonseca Anamnestic Index
OTHER
Ferrans&Powers Quality of Life Index Diabetes Version
OTHER
Lead Sponsor
Bandırma Onyedi Eylül University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04642911